Auszug
Die erhebliche Steigerung der individuellen Lebenserwartung im 20. Jahrhundert hat den Bevölkerungsaufbau in den Industrienationen nachhaltig verändert, so dass ältere Menschen einen immer grüßer werdenden Teil der Bevölkerung ausmachen. Eine der Folgen hiervon ist auch ein Anstieg altersassoziierter Erkrankungen in unserer Gesellschaft. Eine der wohl wichtigsten Gruppen der altersassoziierten Erkrankungen sind die Demenzerkrankungen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Almeida OP, Flicker L (2005) Association between hormone replacement therapy and dementia: is it time to forget? Int Psychogeriatr 17:155–164
Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L (2006) A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging 27:141–149
Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999) Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53:1992–1997
Asthana S (2005) Estrogen, cognition, and dementia. Ann NY Acad Sci 1055:228
Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, Plymate SR (2001) High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57:605–612
Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D’Agostino RB (1993) Incidence of dementia and probable Alzheimer’s disease in a general population: the Framingham Study. Neurology 43:515–519
Baldereschi M, Di CA, Lepore V, Bracco L, Maggi S, Grigoletto F, Scarlato G, Amaducci L (1998) Estrogen-replacement therapy and Alzheimer’s disease in the Italian Longitudinal Study on Aging. Neurology 50:996–1002
Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62:685–691
Bayles KA, Azuma T, Cruz RF, Tomoeda CK, Wood JA, Montgomery EB, Jr. (1999) Gender differences in language of Alzheimer disease patients revisited. Alzheimer Dis Assoc Disord 13:138–146
Behl C (2001) Estrogens against Alzheimer disease? The female sexual hormone as a protective neurohormone. MMW Fortschr Med 143Suppl 2:33–35
Behl C, Manthey D (2000) Neuroprotective activities of estrogen: an update. J Neurocytol 29:351–358
Berr C, Wancata J, Ritchie K (2005) Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol 15:463–471
Bickel H (2000) Dementia syndrome and Alzheimer disease: an assessment of morbidity and annual incidence in Germany. Gesundheitswesen 62:211–218
Birge SJ, Mortel KF (1997) Estrogen and the treatment of Alzheimer’s disease. Am J Med 103:36S–45S
Bowirrat A, Friedland RP, Korczyn AD (2002) Vascular dementia among elderly Arabs in Wadi Ara. J Neurol Sci 203–204:73–76
Brayne C, Gill C, Huppert FA, Barkley C, Gehlhaar E, Girling DM, O’Connor DW, Paykel ES (1995) Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life. Br J Psychiatry 167:255–262
Bretsky PM, Buckwalter JG, Seeman TE, Miller CA, Poirier J, Schellenberg GD, Finch CE, Henderson VW (1999) Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 13:216–221
Buchanan RJ, Wang S, Ju H, Graber D (2004) Analyses of gender differences in profiles of nursing home residents with Alzheimer’s disease. Gend Med 1:48–59
Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW (1993) Gender differences on a brief measure of cognitive functioning in Alzheimer’s disease. Arch Neurol 50:757–760
Buckwalter JG, Rizzo AA, McCleary R, Shankle R, Dick M, Henderson VW (1996) Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia. Arch Neurol 53:436–439
Chiu NT, Lee BF, Hsiao S, Pai MC (2004) Educational level influences regional cerebral blood flow in patients with Alzheimer’s disease. J Nucl Med 45:1860–1863
Chui HC, Lyness SA, Sobel E, Schneider LS (1994) Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer’s disease. Arch Neurol 51:676–681
Claus JJ, Walstra GJ, Bossuyt PM, Teunisse S, van Gool WA (1999) A simple test of copying ability and sex define survival in patients with early Alzheimer’s disease. Psychol Med 29:485–489
Cohen D, Eisdorfer C, Gorelick P, Luchins D, Freels S, Semla T, Paveza G, Shaw H, Ashford JW (1993) Sex differences in the psychiatric manifestations of Alzheimer’s disease. J Am Geriatr Soc 41:229–232
Copeland JR, McCracken CF, Dewey ME, Wilson KC, Doran M, Gilmore C, Scott A, Larkin BA (1999) Undifferentiated dementia, Alzheimer’s disease and vascular dementia: age-and gender-related incidence in Liverpool. The MRC-ALPHA Study. Br J Psychiatry 175:433–438
Cummings JL, Vinters HV, Cole GM, Khachaturian ZS (1998) Alzheimer’s disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51: S2–17
Di CA, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D (2002) Incidence of dementia, Alzheimer’s disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 50:41–48
Diehl J, Kurz A (2002) Frontotemporal dementia: patient characteristics, cognition, and behaviour. Int J Geriatr Psychiatry 17:914–918
Diehl RR (2003) Dementia. Fortschr Neurol Psychiatr 71:617–628
Diprete TA, Buchmann C (2006) Gender-specific trends in the value of education and the emerging gender gap in college completion. Demography 43:1–24
Doraiswamy PM, Bieber F, Kaiser L, Krishnan KR, Reuning-Scherer J, Gulanski B (1997) The Alzheimer’s Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer’s disease trials. Neurology 48:1511–1517
Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E (2002) Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol 59:1589–1593
Eustace A, Kidd N, Greene E, Fallon C, Bhrain SN, Cunningham C, Coen R, Walsh JB, Coakley D, Lawlor BA (2001) Verbal aggression in Alzheimer’s disease. Clinical, functional and neuropsychological correlates. Int J Geriatr Psychiatry 16:858–861
Farlow MR (1997) Alzheimer’s disease: clinical implications of the apolipoprotein E genotype. Neurology 48:S30–S34
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117
Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, Jones B, Lyketsos C, Dulberg C (2004) Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 52:195–204
Fratiglioni L, Viitanen M, von SE, Tontodonati V, Herlitz A, Winblad B (1997) Very old women at highest risk of dementia and Alzheimer’s disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48:132–138
Freedman MA (2002) Quality of life and menopause: the role of estrogen. J Womens Health (Larchmt) 11:703–718
Fritsch T, McClendon MJ, Smyth KA, Ogrocki PK (2002) Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimer-type dementia. Int Psychogeriatr 14:347–363
Gambassi G, Lapane KL, Landi F, Sgadari A, Mor V, Bernabie R (1999) Gender differences in the relation between comorbidity and mortality of patients with Alzheimer’s disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. Neurology 53:508–516
Gatz M, Fiske A, Reynolds CA, Wetherell JL, Johansson B, Pedersen NL(2003) Sex differences in genetic risk for dementia. Behav Genet 33:95–105
Granholm AC (2000) Oestrogen and nerve growth factor — neuroprotection and repair in Alzheimer’s disease. Expert Opin Investig Drugs 9:685–694
Greene RA (2000) Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer’s disease. Int J Fertil Womens Med 45:253–257
Hagnell O, Lanke J, Rorsman B, Ohman R, Ojesjo L (1983) Current trends in the incidence of senile and multi-infarct dementia. A prospective study of a total population followed over 25 years; the Lundby Study. Arch Psychiatr Nervenkr 233:423–438
Halpern DF (1997) Sex differences in intelligence. Implications for education. Am Psychol 52:1091–1102
Harman SM, Naftolin F, Brinton EA, Judelson DR (2005) Is the estrogen controversy over? Deconstructing the Women’s Health Initiative Study: A critical evaluation of the evidence. Ann NY Acad Sci 1052:43–56
Hayward CS, Kelly RP, Collins P (2000) The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46:28–49
Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ, Funkenstein HH, Evans DA (1995) Age-specific incidence of Alzheimer’s disease in a community population. JAMA 273:1354–1359
Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA (2001) Is the risk of developing Alzheimer’s disease greater for women than for men? Am J Epidemiol 153:132–136
Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwaiter JG (1994) Estrogen replacement therapy in older women. Comparisons between Alzheimer’s disease cases and nondemented control subjects. Arch Neurol 51:896–900
Henderson VW, Buckwalter JG (1994) Cognitive deficits of men and women with Alzheimer’s disease. Neurology 44:90–96
Henderson VW, Watt L, Buckwalter JG (1996) Cognitive skills associated with estrogen replacement in women with Alzheimer’s disease. Psychoneuroendocrinology 21:421–430
Henderson VW (1997) The epidemiology of estrogen replacement therapy and Alzheimer’s disease. Neurology 48: S27–S35
Henderson VW (1997) Estrogen, cognition, and a woman’s risk of Alzheimer’s disease. Am J Med 103:11S–18S
Henderson VW (2004) Hormone therapy and Alzheimer’s disease: benefit or harm? Expert Opin Pharmacother 5:389–406
Henderson VW (2006) Estrogen-containing hormone therapy and Alzheimer’s disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138:1031–1039
Hogervorst E, Yaffe K, Richards M, Huppert F (2002) Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst Rev CD003799
Inestrosa NC, Marzolo MR, Bonnefont AB (1998) Cellular and molecular basis of estrogen’s neuroprotection. Potential relevance for Alzheimer’s disease. Mol Neurobiol 17:73–86
Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739:198–210
Jost BC, Grossberg GT (1996) The evolution of psychiatric symptoms in Alzheimer’s disease: a natural history study. J Am Geriatr Soc 44:1078–1081
Lambert JC, Coyle N, Lendon C (2004) The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer’s disease. J Med Genet 41:104–112
Lapane KL, Gambassi G, Landi F, Sgadari A, Mor V, Bernabei R (2001) Gender differences in predictors of mortality in nursing home residents with AD. Neurology 56:650–654
Lee DY, Lee JH, Ju YS, Lee KU, Kim KW, Jhoo JH, Yoon JC, Ha J, Woo JI (2002) The prevalence of dementia in older people in an urban population of Korea: the Seoul study. J Am Geriatr Soc 50:1233–1239
McPherson S, Back C, Buckwalter JG, Cummings JL (1999) Gender-related cognitive deficits in Alzheimer’s disease. Int Psychogeriatr 11:117–122
Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K (2000) Cardiovascular and other risk factors for Alzheimer’s disease and vascular dementia. Ann NY Acad Sci 903:411–423
Miller VM, Clarkson TB, Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Naftolin F, Santoro N (2005) Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol 99:381–383
Mortimer JA, Ebbitt B, Jun SP, Finch MD (1992) Predictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology 42:1689–1696
O’Hara R, Thompson JM, Kraemer HC, Fenn C, Taylor JL, Ross L, Yesavage JA, Bailey AM, Tinklenberg JR (2002) Which Alzheimer patients are at risk for rapid cognitive decline? J Geriatr Psychiatry Neurol 15:233–238
Ott BR, Tate CA, Gordon NM, Heindel WC (1996) Gender differences in the behavioral manifestations of Alzheimer’s disease. J Am Geriatr Soc 44:583–587
Ott BR, Lapane KL, Gambassi G (2000) Gender differences in the treatment of behavior problems in Alzheimer’s disease. SAGE Study Group. Systemic assessment of geriatric drug use via epidemiology. Neurology 54:427–432
Paganini-Hill A, Henderson VW (1996) Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156:2213–2217
Paykel ES, Brayne C, Huppert FA, Gill C, Barkley C, Gehlhaar E, Beardsall L, Girling DM, Pollitt P, O’Connor D (1994) Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 51:325–332
Pinkerton JV, Henderson VW (2005) Estrogen and cognition, with a focus on Alzheimer’s disease. Semin Reprod Med 23:172–179
Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D (2003) Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663–2672
Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58:1615–1621
Ripich DN, Petrill SA, Whitehouse PJ, Ziol EW (1995) Gender differences in language of AD patients: a longitudinal study. Neurology 45:299–302
Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM (2001) Incidence of dementia: does gender make a difference? Neurobiol Aging 22:575–580
Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz L, Looi JC, Berman K, Ross A, Wen W, Zagami AS (2006) Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: The Sydney Stroke Study. Dement Geriatr Cogn Disord 21:275–283
Santoro N (2005) The menopausal transition. Am J Med 118:8–13
Sohrabji F (2005) Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Ann NY Acad Sci 1052:75–90
Schaufele M, Bickel H, Weyerer S (2002) Which factors influence cognitive decline in older adults suffering from dementing disorders? Int J Geriatr Psychiatry 17:1055–1063
Schneider LS, Farlow MR, Pogoda JM (1997) Potential role for estrogen replacement in the treatment of Alzheimer’s dementia. Am J Med 103:46S–50S
Schonknecht P, Henze M, Hunt A, Klinga K, Haberkorn U, Schroder J (2003) Hippocampal glucose metabolism is associated with cerebrospinal fluid estrogen levels in post-menopausal women with Alzheimer’s disease. Psychiatry Res 124:125–127
Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA (2001) Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol 58:435–440
Sherwin BB, McGill J (2003) Oestrogen plus progestin doubles the risk of dementia in post-menopausal women. Evid Based Ment Health 6:111
Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, III, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651–2662
Shumaker SA, Legault C, Kuller L, Rapp SR, Thai L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 291:2947–2958
Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman J, Kramer-Ginsberg E, Searcey T, Bierer L, Davis KL (1994) A longitudinal study of Alzheimer’s disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 151:390–396
Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F (1994) Utility of extra-pyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer’s disease: prospective analyses from the Predictors Study. Neurology 44:2300–2307
Strittmatter WJ (2000) Apolipoprotein E and Alzheimer’s disease. Ann NY Acad Sci 924:91–92
Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348:429–432
Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC (2000) Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54:2061–2066
Weiss EM, Deisenhammer EA, Hinterhuber H, Marksteiner J (2005) Gender differences in cognitive functions. Fortschr Neurol Psychiatr 73:587–595
Wilson RS, Li Y, Aggarwal NT, Barnes LL, McCann JJ, Gilley DW, Evans DA (2004) Education and the course of cognitive decline in Alzheimer disease. Neurology 63:1198–1202
Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K (1995) Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45:1161–1168
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Kunz, M., Lautenbacher, S. (2007). Demenz bei Frauen und Männern: das gleiche Problem?. In: Lautenbacher, S., Güntürkün, O., Hausmann, M. (eds) Gehirn und Geschlecht. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71628-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-540-71628-0_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71627-3
Online ISBN: 978-3-540-71628-0
eBook Packages: Humanities, Social Science (German Language)